A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2

BACKGROUND: Both the map3 Cellular Allogeneic Bone Graft® and recombinant human bone morphogenetic protein 2 (rhBMP-2, Infuse®) were developed to provide an alternative to iliac crest autograft, thus eliminating the morbidity associated with its harvest. The recent literature concerning adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Daniel Dongwhan, Kim, John Yongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574155/
https://www.ncbi.nlm.nih.gov/pubmed/28841904
http://dx.doi.org/10.1186/s13018-017-0618-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574155/
https://www.ncbi.nlm.nih.gov/pubmed/28841904
http://dx.doi.org/10.1186/s13018-017-0618-8

Ejemplares similares